13F-HR filed by Signpost Capital Advisors, LP
Signpost Capital Advisors, LP filed this 13F-HR for the quarter ended 2017-03-31, filed 2017-05-01, with 7 holding rows worth $34,236,000.
- Accession
- 0001560812-17-000006
- Filer
- CIK 1560812
- Filed
- 2017-05-01
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2017
A holdings report, 11 entries on the cover page, a total value of $34,236,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $34,236,000 with VALUE read as thousands by filing date, 13F file number 028-15208. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerSignpost Capital Master Fund Ltd.028-15210
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TRIPADVISOR INC | 896945201 | COM | 241,229 | $10,411,000 | thousands by filing date | |
| CALPINE CORP | 131347304 | COM | 942,103 | $10,411,000 | thousands by filing date | |
| SERITAGE GROWTH PPTYS | 81752R100 | CL A | 116,281 | $5,017,000 | thousands by filing date | |
| DAVITA INC COM | 23918K108 | Stock | 63,506 | $4,316,000 | thousands by filing date | |
| MEDICINES CO | 584688105 | COM | 34,423 | $1,683,000 | thousands by filing date | |
| RETROPHIN INC | 761299106 | COM | 84,111 | $1,553,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 16,485 | $845,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001560812-17-000006 | this filing | 2017-05-01 | acceptance time not in the bulk data set |